Re-Imbursed Pharmaceutical Market

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Austria grew 2.3points of Re-Imbursed Pharmaceutical Market in 2019, compared to the previous year.
  2. Since 2014 United Kingdom Re-Imbursed Pharmaceutical Market grew 2.6points year on year close to 38.5 Percent of Generics in Value.
  3. In 2019 Austria was number 1 in Re-Imbursed Pharmaceutical Market.
  4. In 2019 Portugal was ranked number 7 in Re-Imbursed Pharmaceutical Market at 26.1 Percent of Generics in Value, moving from 8 in 2018.

Top Countries in Re-Imbursed Pharmaceutical Market

# 17 Countries Percent of Generics in Value Last YoY 5‑years CAGR
1 #1
Austria
52.60 % 2019 +2.3 % +2.3 % View data
2 #2
United Kingdom
38.50 % 2019 +2.1 % +2.6 % View data
3 #3
Germany
34.50 % 2019 -0.3 % -1.0 % View data
4 #4
New Zealand
33.30 % 2019 +1.8 % +0.8 % View data
5 #5
Turkey
31.90 % 2019 -0.3 % +0.7 % View data
6 #6
Canada
28.90 % 2019 -1.0 % -2.6 % View data
7 #7
Portugal
26.10 % 2019 +2.8 % +1.6 % View data
8 #8
Slovakia
25.40 % 2019 -4.2 % -7.7 % View data
9 #9
Spain
24.50 % 2019 +3.4 % +2.4 % View data
10 #10
Greece
22.70 % 2019 +0.4 % +3.6 % View data
11 #11
Switzerland
20.70 % 2019 +3.0 % +1.8 % View data
12 #12
Denmark
18.70 % 2019 +1.6 % +3.4 % View data
13 #13
Netherlands
17.90 % 2019 +1.1 % +1.6 % View data
14 #14
Ireland
16.00 % 2019 +2.6 % -0.5 % View data
15 #15
Belgium
14.40 % 2019 +2.1 % +1.6 % View data
16 #16
Italy
9.40 % 2019 +2.2 % +1.6 % View data
17 #17
Luxembourg
6.00 % 2019 +3.5 % +5.0 % View data

Source: OECD

Go Top